Taken together, these data suggest that EGF/HB-EGF-EGFR signalling is required for the proliferative ability of HPV+ cervical cancer cells, and this signalling axis is reduced in cells in which JNK is inhibited. The gene discussed is EGFR; the disease is cervical cancer.